share_log

Cardio Diagnostics Holdings | 8-K: Current report

SEC announcement ·  Jan 4 13:00
Summary by Futu AI
On January 4, 2024, Cardio Diagnostics Holdings, Inc. and YA II PN, Ltd., an affiliate of Yorkville Advisors Global, LP, mutually agreed to terminate their Securities Purchase Agreement originally dated March 8, 2023. The agreement, which had facilitated the issue and sale of a $5.0 million Convertible Debenture by Cardio Diagnostics to Yorkville, also outlined the conditions for a second Convertible Debenture worth $6.2 million. However, the first debenture has been fully repaid and the obligations for the second debenture have now been nullified with no outstanding borrowings, advance notices, or shares to be issued. The termination of the agreement did not incur any fees for either party.
On January 4, 2024, Cardio Diagnostics Holdings, Inc. and YA II PN, Ltd., an affiliate of Yorkville Advisors Global, LP, mutually agreed to terminate their Securities Purchase Agreement originally dated March 8, 2023. The agreement, which had facilitated the issue and sale of a $5.0 million Convertible Debenture by Cardio Diagnostics to Yorkville, also outlined the conditions for a second Convertible Debenture worth $6.2 million. However, the first debenture has been fully repaid and the obligations for the second debenture have now been nullified with no outstanding borrowings, advance notices, or shares to be issued. The termination of the agreement did not incur any fees for either party.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.